img
Welcome to Biotechgate, your source for life science information.
Company Profile Preview
Company
Therapeutics
Technologies
Clinical trials
License agreements
Financing rounds
Management
Business interest
Financials
Investment portfolio
Reports & Forecasts
Company logo

Merck & Co., Inc.

Headquarters
Rahway, USA
See full record

Main sector:

Pharma (fully integrated)

Subsectors:

Antibodies
Anti-infectives
Biosimilars
Nucleic acid drugs
Peptides
Proteins
Small molecule therapeutics
Vaccines
Antibody-drug-conjugate

Indications:

Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Diseases of the ear / otology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Products

In development: 115
On the market: 43

Description:

Merck & Co is a healthcare manufacturer and distributor of pharmaceuticals. The company operates through two segments: pharmaceutical and animal health. The pharmaceutical segment includes human health pharmaceutical and vaccine products that consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies,...

 

Log in to see full record »

No account yet?

Try Biotechgate now - learn about subscription plans and pricing!
Learn more Request a demo
© 2026 Venture Valuation
Terms of Use & Privacy Policy